Latest News for: herpes simplex

Edit

Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex ...

Nasdaq Globe Newswire 05 Feb 2026
Aicuris today announced positive results from its pivotal Phase 3 trial evaluating pritelivir in immunocompromised patients with refractory HSV ... .
  • 1
×